A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer

Catterina Ferreccio, Maria C. Bratti, Mark E. Sherman, Rolando Herrero, Sholom Wacholder, Allan Hildesheim, Robert D. Burk, Martha Hutchinson, Mario Alfaro, Mitchell D. Greenberg, Jorge Morales, Ana C. Rodriguez, John Schussler, Claire Eklund, Guillermo Marshall, Mark Schiffman

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Increased understanding of human papillomavirus (HPV) infection as the central cause of cervical cancer has permitted the development of improved screening techniques. To evaluate their usefulness, we evaluated the performance of multiple screening methods concurrently in a large population-based cohort of >8500 nonvirginal women without hysterectomies, whom we followed prospectively in a high-risk region of Latin America. Using Youden's index as a measure of the trade-off between sensitivity and specificity, we estimated the performances of a visual screening method (cervicography), conventional cytology, liquid-based cytology (ThinPrep), and DNA testing for 13 oncogenic HPV types. The reference standard of disease was neoplasia: cervical intraepithelial neoplasia grade 3 (CIN 3), defined as histologically confirmed CIN 3 detected within 2 years of enrollment (n = 90) or invasive cancer detected within 7 years (n = 20). We analyzed each technique alone and in paired combinations (n = 112 possible strategies), and evaluated the significance of differences between strategies using a paired Z test that equally weighted sensitivity and specificity. As a single test, either liquid-based cytology or HPV DNA testing was significantly more accurate than conventional cytology or cervicography. Paired tests incorporating either liquid-based cytology or HPV DNA testing were not substantially more accurate than either of those two test strategies alone. However, a possibly useful synergy was observed between the conventional smear and cervicography. Consideration of age or behavioral risk profiles did not alter any of these conclusions. Overall, we conclude that highly accurate screening for cervical cancer and CIN 3 is now technically feasible. The remaining vital issue is to extend improved cervical cancer prevention programs to resource-poor regions.

Original languageEnglish (US)
Pages (from-to)815-823
Number of pages9
JournalCancer Epidemiology Biomarkers and Prevention
Volume12
Issue number9
StatePublished - Sep 1 2003

Fingerprint

Uterine Cervical Neoplasms
Cell Biology
Cervical Intraepithelial Neoplasia
DNA
Sensitivity and Specificity
Papillomavirus Infections
Latin America
Hysterectomy
Neoplasms
Population

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Ferreccio, C., Bratti, M. C., Sherman, M. E., Herrero, R., Wacholder, S., Hildesheim, A., ... Schiffman, M. (2003). A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. Cancer Epidemiology Biomarkers and Prevention, 12(9), 815-823.

A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. / Ferreccio, Catterina; Bratti, Maria C.; Sherman, Mark E.; Herrero, Rolando; Wacholder, Sholom; Hildesheim, Allan; Burk, Robert D.; Hutchinson, Martha; Alfaro, Mario; Greenberg, Mitchell D.; Morales, Jorge; Rodriguez, Ana C.; Schussler, John; Eklund, Claire; Marshall, Guillermo; Schiffman, Mark.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 12, No. 9, 01.09.2003, p. 815-823.

Research output: Contribution to journalArticle

Ferreccio, C, Bratti, MC, Sherman, ME, Herrero, R, Wacholder, S, Hildesheim, A, Burk, RD, Hutchinson, M, Alfaro, M, Greenberg, MD, Morales, J, Rodriguez, AC, Schussler, J, Eklund, C, Marshall, G & Schiffman, M 2003, 'A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer', Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 9, pp. 815-823.
Ferreccio, Catterina ; Bratti, Maria C. ; Sherman, Mark E. ; Herrero, Rolando ; Wacholder, Sholom ; Hildesheim, Allan ; Burk, Robert D. ; Hutchinson, Martha ; Alfaro, Mario ; Greenberg, Mitchell D. ; Morales, Jorge ; Rodriguez, Ana C. ; Schussler, John ; Eklund, Claire ; Marshall, Guillermo ; Schiffman, Mark. / A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. In: Cancer Epidemiology Biomarkers and Prevention. 2003 ; Vol. 12, No. 9. pp. 815-823.
@article{4ea57060f16847ec986026495b3dd42a,
title = "A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer",
abstract = "Increased understanding of human papillomavirus (HPV) infection as the central cause of cervical cancer has permitted the development of improved screening techniques. To evaluate their usefulness, we evaluated the performance of multiple screening methods concurrently in a large population-based cohort of >8500 nonvirginal women without hysterectomies, whom we followed prospectively in a high-risk region of Latin America. Using Youden's index as a measure of the trade-off between sensitivity and specificity, we estimated the performances of a visual screening method (cervicography), conventional cytology, liquid-based cytology (ThinPrep), and DNA testing for 13 oncogenic HPV types. The reference standard of disease was neoplasia: cervical intraepithelial neoplasia grade 3 (CIN 3), defined as histologically confirmed CIN 3 detected within 2 years of enrollment (n = 90) or invasive cancer detected within 7 years (n = 20). We analyzed each technique alone and in paired combinations (n = 112 possible strategies), and evaluated the significance of differences between strategies using a paired Z test that equally weighted sensitivity and specificity. As a single test, either liquid-based cytology or HPV DNA testing was significantly more accurate than conventional cytology or cervicography. Paired tests incorporating either liquid-based cytology or HPV DNA testing were not substantially more accurate than either of those two test strategies alone. However, a possibly useful synergy was observed between the conventional smear and cervicography. Consideration of age or behavioral risk profiles did not alter any of these conclusions. Overall, we conclude that highly accurate screening for cervical cancer and CIN 3 is now technically feasible. The remaining vital issue is to extend improved cervical cancer prevention programs to resource-poor regions.",
author = "Catterina Ferreccio and Bratti, {Maria C.} and Sherman, {Mark E.} and Rolando Herrero and Sholom Wacholder and Allan Hildesheim and Burk, {Robert D.} and Martha Hutchinson and Mario Alfaro and Greenberg, {Mitchell D.} and Jorge Morales and Rodriguez, {Ana C.} and John Schussler and Claire Eklund and Guillermo Marshall and Mark Schiffman",
year = "2003",
month = "9",
day = "1",
language = "English (US)",
volume = "12",
pages = "815--823",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer

AU - Ferreccio, Catterina

AU - Bratti, Maria C.

AU - Sherman, Mark E.

AU - Herrero, Rolando

AU - Wacholder, Sholom

AU - Hildesheim, Allan

AU - Burk, Robert D.

AU - Hutchinson, Martha

AU - Alfaro, Mario

AU - Greenberg, Mitchell D.

AU - Morales, Jorge

AU - Rodriguez, Ana C.

AU - Schussler, John

AU - Eklund, Claire

AU - Marshall, Guillermo

AU - Schiffman, Mark

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Increased understanding of human papillomavirus (HPV) infection as the central cause of cervical cancer has permitted the development of improved screening techniques. To evaluate their usefulness, we evaluated the performance of multiple screening methods concurrently in a large population-based cohort of >8500 nonvirginal women without hysterectomies, whom we followed prospectively in a high-risk region of Latin America. Using Youden's index as a measure of the trade-off between sensitivity and specificity, we estimated the performances of a visual screening method (cervicography), conventional cytology, liquid-based cytology (ThinPrep), and DNA testing for 13 oncogenic HPV types. The reference standard of disease was neoplasia: cervical intraepithelial neoplasia grade 3 (CIN 3), defined as histologically confirmed CIN 3 detected within 2 years of enrollment (n = 90) or invasive cancer detected within 7 years (n = 20). We analyzed each technique alone and in paired combinations (n = 112 possible strategies), and evaluated the significance of differences between strategies using a paired Z test that equally weighted sensitivity and specificity. As a single test, either liquid-based cytology or HPV DNA testing was significantly more accurate than conventional cytology or cervicography. Paired tests incorporating either liquid-based cytology or HPV DNA testing were not substantially more accurate than either of those two test strategies alone. However, a possibly useful synergy was observed between the conventional smear and cervicography. Consideration of age or behavioral risk profiles did not alter any of these conclusions. Overall, we conclude that highly accurate screening for cervical cancer and CIN 3 is now technically feasible. The remaining vital issue is to extend improved cervical cancer prevention programs to resource-poor regions.

AB - Increased understanding of human papillomavirus (HPV) infection as the central cause of cervical cancer has permitted the development of improved screening techniques. To evaluate their usefulness, we evaluated the performance of multiple screening methods concurrently in a large population-based cohort of >8500 nonvirginal women without hysterectomies, whom we followed prospectively in a high-risk region of Latin America. Using Youden's index as a measure of the trade-off between sensitivity and specificity, we estimated the performances of a visual screening method (cervicography), conventional cytology, liquid-based cytology (ThinPrep), and DNA testing for 13 oncogenic HPV types. The reference standard of disease was neoplasia: cervical intraepithelial neoplasia grade 3 (CIN 3), defined as histologically confirmed CIN 3 detected within 2 years of enrollment (n = 90) or invasive cancer detected within 7 years (n = 20). We analyzed each technique alone and in paired combinations (n = 112 possible strategies), and evaluated the significance of differences between strategies using a paired Z test that equally weighted sensitivity and specificity. As a single test, either liquid-based cytology or HPV DNA testing was significantly more accurate than conventional cytology or cervicography. Paired tests incorporating either liquid-based cytology or HPV DNA testing were not substantially more accurate than either of those two test strategies alone. However, a possibly useful synergy was observed between the conventional smear and cervicography. Consideration of age or behavioral risk profiles did not alter any of these conclusions. Overall, we conclude that highly accurate screening for cervical cancer and CIN 3 is now technically feasible. The remaining vital issue is to extend improved cervical cancer prevention programs to resource-poor regions.

UR - http://www.scopus.com/inward/record.url?scp=0141563682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141563682&partnerID=8YFLogxK

M3 - Article

C2 - 14504189

AN - SCOPUS:0141563682

VL - 12

SP - 815

EP - 823

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 9

ER -